
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
A team of patient advocates from the National Cancer Institute's National Clinical Trials Network has chosen the Center for Information and Study on Clinical Research Participation to lead a project that will result in a template for describing NCI-funded cancer clinical trials actively recruiting patients. The plain language trial summary template for patients will be available to all members in the National Cancer Institute's National Clinical Trials Network.
For more, click






